These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35346803)

  • 1. Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer.
    Ganguly K; Shah A; Atri P; Rauth S; Ponnusamy MP; Kumar S; Batra SK
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):511-520. PubMed ID: 35346803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy.
    Luong T; Golivi Y; Nagaraju GP; El-Rayes BF
    Cytokine Growth Factor Rev; 2022 Dec; 68():107-115. PubMed ID: 36096869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
    Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
    Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer.
    Stouten I; van Montfoort N; Hawinkels LJAC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.
    Ge W; Yue M; Wang Y; Wang Y; Xue S; Shentu D; Mao T; Zhang X; Xu H; Li S; Ma J; Wang L; Cui J
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts: A key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma.
    Luo W; Zhang T
    Cancer Lett; 2023 Jul; 567():216279. PubMed ID: 37336287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
    Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
    J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer.
    Higashiguchi M; Murakami H; Akita H; Kobayashi S; Takahama S; Iwagami Y; Yamada D; Tomimaru Y; Noda T; Gotoh K; Doki Y; Yamamoto T; Eguchi H
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer.
    Li Y; Wang J; Wang H; Zhang S; Wei Y; Liu S
    Front Immunol; 2022; 13():850093. PubMed ID: 35493517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
    Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
    Front Immunol; 2023; 14():1152312. PubMed ID: 37033960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment.
    Xiang X; Niu YR; Wang ZH; Ye LL; Peng WB; Zhou Q
    Cytokine Growth Factor Rev; 2022 Oct; 67():35-48. PubMed ID: 35918210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer.
    Zhang Z; Zhang H; Shi L; Wang D; Tang D
    Immunology; 2022 Sep; 167(1):1-14. PubMed ID: 35569095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucins in pancreatic cancer and its microenvironment.
    Kaur S; Kumar S; Momi N; Sasson AR; Batra SK
    Nat Rev Gastroenterol Hepatol; 2013 Oct; 10(10):607-20. PubMed ID: 23856888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment.
    Garcia Garcia CJ; Huang Y; Fuentes NR; Turner MC; Monberg ME; Lin D; Nguyen ND; Fujimoto TN; Zhao J; Lee JJ; Bernard V; Yu M; Delahoussaye AM; Jimenez Sacarello I; Caggiano EG; Phan JL; Deorukhkar A; Molkentine JM; Saur D; Maitra A; Taniguchi CM
    Gastroenterology; 2022 Jun; 162(7):2018-2031. PubMed ID: 35216965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Senescence, Represented by Expression of Caveolin-1, in Cancer-Associated Fibroblasts Promotes Tumor Invasion in Pancreatic Cancer.
    Yamao T; Yamashita YI; Yamamura K; Nakao Y; Tsukamoto M; Nakagawa S; Okabe H; Hayashi H; Imai K; Baba H
    Ann Surg Oncol; 2019 May; 26(5):1552-1559. PubMed ID: 30805811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.
    Hussain S; Peng B; Cherian M; Song JW; Ahirwar DK; Ganju RK
    Front Immunol; 2020; 11():598532. PubMed ID: 33414786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.